Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.12−0.02 (-1.75%)
Close on Nov 13, 2026Market cap $195.18MP/E –Yield –
Palisade Bio operating margin
Operating margin is operating income as a percentage of revenue.
Palisade Bio's operating margin for the twelve months ending Sep 30, 2026 was -9625.4%. For fiscal 2023 it was -5228.0%, against -68764.8% the year before. The highest annual figure on record is -2070.4% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -5228.0% | +63536.8 |
| FY2020 | Dec 31, 2020 | -68764.8% | −12693.0 |
| FY2019 | Dec 31, 2019 | -56071.8% | −52895.1 |
| FY2018 | Dec 31, 2018 | -3176.7% | +1941.4 |
| FY2017 | Dec 31, 2017 | -5118.1% | +121909.1 |
| FY2016 | Dec 31, 2016 | -127027.2% | +56869.6 |
| FY2015 | Dec 31, 2015 | -183896.8% | −91315.4 |
| FY2014 | Dec 31, 2014 | -92581.4% | −81196.0 |
| FY2013 | Dec 31, 2013 | -11385.4% | −8894.3 |
| FY2012 | Dec 31, 2012 | -2491.1% | +834.5 |
| FY2011 | Dec 31, 2011 | -3325.6% | −1255.2 |
| FY2010 | Dec 31, 2010 | -2070.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2339.6% | +71300.4 |
| Q1 FY2023 | Mar 31, 2023 | -1011.6% | +32052.6 |
| Q4 FY2020 | Dec 31, 2020 | -129800.0% | −44497.1 |
| Q3 FY2020 | Sep 30, 2020 | -72640.0% | +12327.0 |
| Q2 FY2020 | Jun 30, 2020 | -73640.0% | −49338.2 |
| Q1 FY2020 | Mar 31, 2020 | -33064.2% | +65198.4 |
| Q4 FY2019 | Dec 31, 2019 | -85302.9% | −13110.3 |
| Q3 FY2019 | Sep 30, 2019 | -84967.0% | −1660.0 |
| Q2 FY2019 | Jun 30, 2019 | -24301.8% | −23500.6 |
| Q1 FY2019 | Mar 31, 2019 | -98262.6% | −4302.8 |
| Q4 FY2018 | Dec 31, 2018 | -72192.6% | −71294.0 |
| Q3 FY2018 | Sep 30, 2018 | -83307.0% | +20208.0 |
| Q2 FY2018 | Jun 30, 2018 | -801.2% | +167928.1 |
| Q1 FY2018 | Mar 31, 2018 | -93959.8% | +75320.5 |
| Q4 FY2017 | Dec 31, 2017 | -898.6% | +63724.7 |
| Q3 FY2017 | Sep 30, 2017 | -103514.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -168729.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -169280.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -64623.3% | – |
See a number that looks wrong?